Medpace CEO August Troendle sells about 48,700 shares near $621–$625

Medpace Holdings President and CEO August J. Troendle reported sizable open-window stock sales. A Form 4 filed Thursday shows he sold 26,701 common shares on Sept. 29, 2026, at a weighted-average price of $621.02 (trades from $620.00 to $622.35) and another 21,966 shares on Sept. 30 at a weighted-average $625.47 (trades from $620.105 to $628.08).

A footnote says the transactions were effected pursuant to a limit order placed during an open window period. The form’s Rule 10b5-1 checkbox is not marked. After the Sept. 30 sale, Troendle reported 338,225 shares held directly. He also reported 4,733,019 shares held indirectly by Medpace Investors, LLC, where he is sole manager and controlling unit holder, while disclaiming beneficial ownership except for his pecuniary interest.

Combined, the two sales covered 48,667 shares. At the reported weighted averages, proceeds were roughly $16.6 million on Sept. 29 and about $13.7 million on Sept. 30, or about $30.3 million in total.

By the numbers

• Sept. 29 sale: 26,701 shares @ WA $621.02
• Sept. 30 sale: 21,966 shares @ WA $625.47
• Direct holdings after: 338,225 shares
• Indirect via Medpace Investors, LLC: 4,733,019 shares

Sources

1. Medpace Holdings, Inc. Form 4 (August J. Troendle), period of report Sept. 29, 2026, accession 0001622058-26-000022

This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.

Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.